Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 315

1.

The use of trazodone as a hypnotic: a critical review.

James SP, Mendelson WB.

J Clin Psychiatry. 2004 Jun;65(6):752-5. Review.

PMID:
15291651
2.

A review of the evidence for the efficacy and safety of trazodone in insomnia.

Mendelson WB.

J Clin Psychiatry. 2005 Apr;66(4):469-76. Review.

PMID:
15816789
3.

The treatment of chronic insomnia: drug indications, chronic use and abuse liability. Summary of a 2001 New Clinical Drug Evaluation Unit meeting symposium.

Mendelson WB, Roth T, Cassella J, Roehrs T, Walsh JK, Woods JH, Buysse DJ, Meyer RE.

Sleep Med Rev. 2004 Feb;8(1):7-17.

PMID:
15062207
4.

Sleep complaints: Whenever possible, avoid the use of sleeping pills.

[No authors listed]

Prescrire Int. 2008 Oct;17(97):206-12.

PMID:
19536941
5.
6.

United States experience and perspectives with trazodone.

Fabre LF.

Clin Neuropharmacol. 1989;12 Suppl 1:S11-7. Review.

PMID:
2663150
7.

Trazodone for the treatment of sleep disorders in dementia: an open-label, observational and review study.

Camargos EF, Pandolfi MB, Freitas MP, Quintas JL, Lima Jde O, Miranda LC, Pimentel W, Medeiros-Souza P.

Arq Neuropsiquiatr. 2011 Feb;69(1):44-9.

8.

Indiplon: a nonbenzodiazepine sedative-hypnotic for the treatment of insomnia.

Marrs JC.

Ann Pharmacother. 2008 Jul;42(7):1070-9. doi: 10.1345/aph.1K683. Epub 2008 Jul 1.

PMID:
18594049
9.

Effect of trazodone in a single dose before bedtime for sleep disorders accompanied by a depressive state: dose-finding study with no concomitant use of hypnotic agent.

Mashiko H, Niwa S, Kumashiro H, Kaneko Y, Suzuki S, Numata Y, Horikoshi R, Watanabe Y.

Psychiatry Clin Neurosci. 1999 Apr;53(2):193-4.

10.

Electroconvulsive therapy and cardiovascular complications in patients taking trazodone for insomnia.

Krahn LE, Hanson CA, Pileggi TS, Rummans TA.

J Clin Psychiatry. 2001 Feb;62(2):108-10.

PMID:
11247094
11.

Trazodone improves the results of cognitive behaviour therapy of primary insomnia in non-depressed patients.

Zavesicka L, Brunovsky M, Horacek J, Matousek M, Sos P, Krajca V, Höschl C.

Neuro Endocrinol Lett. 2008 Dec;29(6):895-901.

PMID:
19112384
12.

Acute behavioral effects and abuse potential of trazodone, zolpidem and triazolam in humans.

Rush CR, Baker RW, Wright K.

Psychopharmacology (Berl). 1999 Jun;144(3):220-33.

PMID:
10435388
13.

Possible trazodone potentiation of fluoxetine: a case series.

Nierenberg AA, Cole JO, Glass L.

J Clin Psychiatry. 1992 Mar;53(3):83-5.

PMID:
1548249
14.

Rational basis for the use of sleeping pills.

Dement WC.

Int Pharmacopsychiatry. 1982;17 Suppl 2:3-38. Review.

PMID:
6765246
15.

Current patterns and future directions in the treatment of insomnia.

Winkelman J, Pies R.

Ann Clin Psychiatry. 2005 Jan-Mar;17(1):31-40. Review.

PMID:
15941029
16.

[Sleep disorders and hypnotic agents: medical, social and economical impact].

Touitou Y.

Ann Pharm Fr. 2007 Jul;65(4):230-8. Review. French.

PMID:
17652991
17.

Sleep terror disorder and insomnia treated with trazodone: a case report.

Balon R.

Ann Clin Psychiatry. 1994 Sep;6(3):161-3.

PMID:
7881496
18.

'Hypnotic' prescription patterns in a large managed-care population.

Roehrs T, Roth T.

Sleep Med. 2004 Sep;5(5):463-6.

PMID:
15341891
19.

Trazodone dosing regimen: experience with single daily administration.

Fabre LF.

J Clin Psychiatry. 1990 Sep;51 Suppl:23-6. Review.

PMID:
2211561
20.

[The effectiveness of treatment with trazodone in patients with primary insomnia without and with prior history of hypnotics use].

Wichniak A, Wierzbicka A, Sobańska A, Szatkowska E, Czasak K, Musińska I, Jernajczyk W.

Pol Merkur Lekarski. 2007 Jul;23(133):41-6. Polish.

PMID:
18051828

Supplemental Content

Support Center